Trial · NCT06095596
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 8th-week endoscopic remission rate | 8th-week | endoscopic subscale (ESS) =0, which defined as endoscopic remission |
| Secondary | Clinical remission rate at the 8th week | 8th-week | Clinical remission is defined as a total Mayo score ≤2, with no individual subscore \>1 and a rectal bleeding subscore of 0. |
| Secondary | clincial response rate at 8th-week | 8th-week | Clinical response is defined as a decrease in total Mayo score by ≥3 points and ≥30% from baseline, with a decrease in rectal bleeding subscore by ≥1 point or an absolute rectal bleeding subscore of 0 or 1. |
| Secondary | Endoscopic response rate at 8th-week | 8th-week | Endoscopic response is defined as a decrease in the Mayo endoscopic subscore by ≥1 point from baseline |
| Secondary | normalization rate of CRP at the 8th week | 8th-week | normalization rate of C reactive protein (CRP) |
| Secondary | life quality score at the 8th week | 8th-week | Inflammatory bowel disease questionnaire (IBDQ), the total score is 32-224, with higher scores indicating better quality of life for patients. |
| Secondary | Clinical remission rate at the 54th-week | 54th-week | clincial remisson is defined as a total Mayo score ≤2, with no individual subscore \>1 and a rectal bleeding subscore of 0. |
| Secondary | Clinical response rate at 54th week | 54th week | Clinical response is defined as a decrease in total Mayo score by ≥3 points and ≥30% from baseline, with a decrease in rectal bleeding subscore by ≥1 point or an absolute rectal bleeding subscore of 0 or 1. |
| Secondary | endoscopic remission rate at 54th-week | 54th-week | endoscopic subscale (ESS) =0, which defined as endoscopic remission |
| Secondary | Endoscopic response rate at 54th-week | 54th-week | Endoscopic response is defined as a decrease in the Mayo endoscopic subscore by ≥1 point from baseline |
| Secondary | normalization rate of CRP at the 54th week | 54th-week | normalization rate of CRP |
| Secondary | life quality score at the 54th week | 54th-week | Inflammatory bowel disease questionnaire (IBDQ), the total score is 32-224, with higher scores indicating better quality of life for patients. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06095596/registered